Skip to content

Application of tetracaine hydrochloride mucilage surface anesthesia combined with simple intravenous anesthesia in painless cystoscopy

Application of tetracaine hydrochloride mucilage surface anesthesia combined with simple intravenous anesthesia in painless cystoscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070527
Enrollment
Unknown
Registered
2023-04-14
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract diseases

Interventions

Intervention group:Tetracaine hydrochloride colloidal surface anesthesia combined with intravenous anesthesia for painless cystoscopy
Control group:Simple intravenous anesthesia for painless cystoscopy

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Male patients 18 years of age or greater with ureteral stents indwelled after the surgery for urinary stones; 2) No contraindications to general anesthesia; 3) Patients who have passed the outpatient general anesthesia evaluation; 4) Be informed about the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with severe cardiopulmonary abnormalities or coagulation disorders that cannot tolerate general anesthesia surgery; 2) Patients assessed by anesthesiologists as unsuitable for painless cystoscopy; 3) Patients with urethral stricture who are unable to undergo cystoscopy; 4) Patients who does not sign informed consent.

Design outcomes

Primary

MeasureTime frame
Intravenous anesthesia drug (propofol) dosage;

Secondary

MeasureTime frame
Completion time of cystoscopy;Depth of intravenous anesthesia;Pain index;Anesthesia recovery time;

Countries

China

Contacts

Public ContactWenjie Bai

Beijing Tsinghua Changgung Hospital

18301209698@163.com+86 18301209698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026